Jannsen Pharmaceutical asserted remarkable improvement in TREMFYA treated patients with plaque…
The Janssen Pharmaceutical Companies of Johnson and Johnson asserted extrapolation of data that exemplified 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at…
Read More...
Read More...